tiprankstipranks
Trending News
More News >
Genetic Signatures Ltd. (AU:GSS)
:GSS
Australian Market
Advertisement

Genetic Signatures Ltd. (GSS) Stock Statistics & Valuation Metrics

Compare
5 Followers

Total Valuation

Genetic Signatures Ltd. has a market cap or net worth of AU$62.46M. The enterprise value is AU$52.40M.
Market CapAU$62.46M
Enterprise ValueAU$52.40M

Share Statistics

Genetic Signatures Ltd. has 227,138,820 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding227,138,820
Owned by Insiders
Owned by Institutions

Financial Efficiency

Genetic Signatures Ltd.’s return on equity (ROE) is -0.40 and return on invested capital (ROIC) is -29.06%.
Return on Equity (ROE)-0.40
Return on Assets (ROA)-0.37
Return on Invested Capital (ROIC)-29.06%
Return on Capital Employed (ROCE)-0.37
Revenue Per Employee
Profits Per Employee
Employee Count
Asset Turnover0.29
Inventory Turnover0.90

Valuation Ratios

The current PE Ratio of Genetic Signatures Ltd. is ―. Genetic Signatures Ltd.’s PEG ratio is ―.
PE Ratio
PS Ratio
PB Ratio
Price to Fair Value1.65
Price to FCF
Price to Operating Cash Flow-5.08
PEG Ratio

Income Statement

In the last 12 months, Genetic Signatures Ltd. had revenue of 15.90M and earned -20.10M in profits. Earnings per share was -0.09.
Revenue15.90M
Gross Profit7.78M
Operating Income-18.48M
Pretax Income-20.10M
Net Income-20.10M
EBITDA-16.08M
Earnings Per Share (EPS)-0.09

Cash Flow

In the last 12 months, operating cash flow was -12.29M and capital expenditures -653.00K, giving a free cash flow of -12.94M billion.
Operating Cash Flow-12.29M
Free Cash Flow-12.94M
Free Cash Flow per Share-0.06

Dividends & Yields

Genetic Signatures Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.36
52-Week Price Change-61.11%
50-Day Moving Average0.34
200-Day Moving Average0.50
Relative Strength Index (RSI)36.03
Average Volume (3m)123.89K

Important Dates

Genetic Signatures Ltd. upcoming earnings date is Mar 4, 2026, TBA (Confirmed).
Last Earnings DateAug 24, 2025
Next Earnings DateMar 4, 2026
Ex-Dividend Date

Financial Position

Genetic Signatures Ltd. as a current ratio of 11.70, with Debt / Equity ratio of 1.58%
Current Ratio11.70
Quick Ratio9.49
Debt to Market Cap<0.01
Net Debt to EBITDA0.42
Interest Coverage Ratio-203.09

Taxes

In the past 12 months, Genetic Signatures Ltd. has paid -3.85M in taxes.
Income Tax-3.85M
Effective Tax Rate0.19

Enterprise Valuation

Genetic Signatures Ltd. EV to EBITDA ratio is -4.73, with an EV/FCF ratio of -5.77.
EV to Sales4.78
EV to EBITDA-4.73
EV to Free Cash Flow-5.77
EV to Operating Cash Flow-6.19

Balance Sheet

Genetic Signatures Ltd. has AU$31.30M in cash and marketable securities with AU$791.00K in debt, giving a net cash position of -AU$30.50M billion.
Cash & Marketable SecuritiesAU$31.30M
Total DebtAU$791.00K
Net Cash-AU$30.50M
Net Cash Per Share-AU$0.13
Tangible Book Value Per ShareAU$0.22

Margins

Gross margin is -15.03%, with operating margin of -116.23%, and net profit margin of -126.44%.
Gross Margin-15.03%
Operating Margin-116.23%
Pretax Margin-126.44%
Net Profit Margin-126.44%
EBITDA Margin-101.11%
EBIT Margin-116.23%

Analyst Forecast

The average price target for Genetic Signatures Ltd. is AU$0.55, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price TargetAU$0.55
Price Target Upside96.43% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast62.81%
EPS Growth Forecast16.37%

Scores

Smart Score4
AI Score40.1
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis